G. W. Sloof

942 total citations
21 papers, 680 citations indexed

About

G. W. Sloof is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. W. Sloof has authored 21 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. W. Sloof's work include Esophageal Cancer Research and Treatment (10 papers), Cardiac Imaging and Diagnostics (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). G. W. Sloof is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Cardiac Imaging and Diagnostics (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). G. W. Sloof collaborates with scholars based in Netherlands, United States and Poland. G. W. Sloof's co-authors include John Th. M. Plukker, Henk Groen, J. Jan B. van Lanschot, Marinke Westerterp, Henderik L. van Westreenen, Peter Bossuyt, J. Pruim, Mark I. van Berge Henegouwen, J. Jan B. van Lanschot and Mark van Heijl and has published in prestigious journals such as Journal of Clinical Oncology, British journal of surgery and Annals of Surgical Oncology.

In The Last Decade

G. W. Sloof

21 papers receiving 660 citations

Peers

Countries citing papers authored by G. W. Sloof

Since Specialization

Citations

This map shows the geographic impact of G. W. Sloof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. W. Sloof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. W. Sloof more than expected).

Fields of papers citing papers by G. W. Sloof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. W. Sloof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. W. Sloof. The network helps show where G. W. Sloof may publish in the future.

Co-authorship network of co-authors of G. W. Sloof

This figure shows the co-authorship network connecting the top 25 collaborators of G. W. Sloof. A scholar is included among the top collaborators of G. W. Sloof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. W. Sloof. G. W. Sloof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study 2016 ·Diseases of the Esophagus ·Pieter van Hagen, Mark van Heijl, Mark I. van Berge Henegouwen, Ronald Boellaard, Patrick M. Bossuyt, F.J.W. ten Kate, Herman van Dekken, Otto S. Hoekstra, G. W. Sloof, J. Jan B. van Lanschot	50
2	FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review 2012 ·Indian Journal of Surgical Oncology ·Jikke M.T. Omloo, Mark van Heijl, Otto S. Hoekstra, Mark I. van Berge Henegouwen, J. Jan B. van Lanschot, G. W. Sloof	19
3	Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer 2011 ·European Journal of Surgical Oncology ·Mark van Heijl, Saffire S.K.S. Phoa, Mark I. van Berge Henegouwen, Jikke M.T. Omloo, Banafsche Mearadji, G. W. Sloof, Patrick M. Bossuyt, Maarten C.C.M. Hulshof, D. J. Richel, Jacques Bergman, F.J.W. ten Kate, Jaap Stoker, J. Jan B. van Lanschot	29
4	FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review 2011 ·Annals of Surgical Oncology ·Jikke M.T. Omloo, Mark van Heijl, Otto S. Hoekstra, Mark I. van Berge Henegouwen, J. Jan B. van Lanschot, G. W. Sloof	52
5	Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer? 2011 ·Annals of Surgical Oncology ·(unknown), A. Cecile J.W. Janssens, Henk Groen, Paul Fockens, Hendrik M. van Dullemen, Mark I. van Berge Henegouwen, G. W. Sloof, Jan Pruim, J. Jan B. van Lanschot, Ewout W. Steyerberg, John Th. M. Plukker	32
6	Additional Value of External Ultrasonography of the Neck after CT and PET Scanning in the Preoperative Assessment of Patients with Esophageal Cancer 2009 ·Digestive Surgery ·Jikke M.T. Omloo, Mark van Heijl, Nico J. Smits, Saffire S.K.S. Phoa, Mark I. van Berge Henegouwen, G. W. Sloof, J. Jan B. van Lanschot	12
7	Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer 2008 ·Endoscopy ·Jikke M.T. Omloo, G. W. Sloof, Ronald Boellaard, Otto S. Hoekstra, P.L. Jager, Hendrik van Dullemen, Paul Fockens, John Th. M. Plukker, Jan van Lanschot	37
8	[The value of positron emission tomography in the diagnosis and treatment of oesophageal cancer]. 2008 ·PubMed ·Jikke M.T. Omloo, Marinke Westerterp, G. W. Sloof, O. S. Hoekstra, J. Jan B. van Lanschot	3
9	Limited additional value of positron emission tomography in staging oesophageal cancer 2007 ·British journal of surgery ·Henderik L. van Westreenen, Marinke Westerterp, G. W. Sloof, Henk Groen, Peter Bossuyt, P.L. Jager, Emile F.I. Comans, Hendrik M. van Dullemen, Paul Fockens, Jaap Stoker, Eric J. van der Jagt, J. Jan B. van Lanschot, John Th. M. Plukker	53
10	Monitoring of response to preoperative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET 2006 ·Journal of Clinical Gastroenterology ·Marinke Westerterp, Jikke M.T. Omloo, G. W. Sloof, Maarten C.C.M. Hulshof, Otto S. Hoekstra, Johannes Crezee, Ronald Boellaard, Walter L. Vervenne, F.J.W. ten Kate, J. Jan B. van Lanschot	4
11	Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node 2004 ·Gynecologic Oncology ·Guus Fons, (unknown), G. W. Sloof, Joanne A. de Hullu, Jacobus van der Velden	32
12	Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography 2003 ·Nuclear Medicine Communications ·G. W. Sloof, F. F. Knapp, Arthur van Lingen, Jos Eersels, Don Poldermans, Jeroen J. Bax	6
13	Agreement and disagreement between “metabolic viability” and “contractile reserve” in akinetic myocardium 1999 ·Journal of Nuclear Cardiology ·Jan H. Cornel, J. J. Bax, Abdou Elhendy, Frans C. Visser, Eric Boersma, Don Poldermans, G. W. Sloof, P. Fioretti	23
14	Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria. 1999 ·PubMed ·Jeroen J. Bax, Frank Visser, Abdou Elhendy, Don Poldermans, Jan H. Cornel, Arthur van Lingen, Eric Boersma, G. W. Sloof, P. Fioretti, C.A. Visser	17
15	Metabolism of radioiodinated fatty acid analogs in ischemic and hypoxic canine myocardium. 1999 ·PubMed ·G. W. Sloof, F. C. Visser, (unknown), J BAX, Tom Teerlink, Ger J. Vusse, F. F. Knapp	1
16	Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. 1998 ·PubMed ·G. W. Sloof, Frank Visser, J. J. Bax, Arthur van Lingen, Jos Eersels, F. F. Knapp, G. J. J. Teule	14
17	Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans 1997 ·Nuclear Medicine Communications ·G. W. Sloof, F. C. Visser, A. van Lingen, J BAX, Jos Eersels, G. J. J. Teule, F. F. Knapp	3
18	Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal models and human studies. 1996 ·PubMed ·(unknown), J. Kropp, Philippe R. Franken, F. C. Visser, G. W. Sloof, Michael Eisenhut, (unknown), Yoshifumi Shirakami, Hideo Kusuoka, Takuya Nishimura	22
19	Comparison of uptake, oxidation and lipid distribution of 17-iodoheptadecanoic acid, 15-(p-iodophenyl)pentadecanoic acid and 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid in normal canine myocardium. 1993 ·PubMed ·G. W. Sloof, F. C. Visser, (unknown), (unknown), Tom Teerlink, Jacobus D. M. Herscheid, Ger J. Vusse, F. F. Knapp	11
20	Incorporation of radioiodinated fatty acids into cardiac phospholipids of normoxic canine myocardium 1992 ·Molecular and Cellular Biochemistry ·G. W. Sloof, F. C. Visser, Tom Teerlink, (unknown), Machiel J. van Eenige, Ger J. Vusse, F. F. Knapp	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact